首页 | 本学科首页   官方微博 | 高级检索  
检索        

右美托咪定辅合全麻对腹腔镜胃切除术后肠麻痹发生的影响
引用本文:苗亚飞.右美托咪定辅合全麻对腹腔镜胃切除术后肠麻痹发生的影响[J].国际医药卫生导报,2017,23(8).
作者姓名:苗亚飞
作者单位:河南科技大学临床医学院河南科技大学第一附属医院麻醉科, 洛阳,471003
摘    要:目的 评价右美托咪定辅合全麻对腹腔镜下胃大部切除术后肠麻痹的影响.方法 择期全麻腹腔镜下胃大部切除患者60例,性别不限,年龄30 ~ 65岁,体重指数20 ~ 25 kg/m2,ASA分级Ⅰ或Ⅱ级,采用随机数字表法分为2组(n=30):常规组(C组)和右美托咪定复合麻醉组(D组).D组行气管插管术后静脉输注右美托咪定1μg/kg持续10 min,随后以0.2 μg·kg-1·h-1速度输注至术后48 h,C组静脉输注等容量生理盐水.术后48 h内行PCIA(舒芬太尼150μg+恩丹司琼16 mg+生理盐水139 ml,输注速率2 ml/h,PCA剂量0.5 ml,锁定时间15 min).于麻醉前即刻(T0)、术后24h (T3)、48 h(T4)时抽取静脉血2ml,采用ELISA法测定血清C-反应蛋白(CRP)浓度及血浆IL-6浓度.记录术后48 h内按压总次数,舒芬太尼用量.记录术后首次排气排便时间.结果 与C组比较,D组患者在T3、T4时IL-6(51±13)pg/ml比(38±12) pg/ml、(39±10) pg/ml比(30±9)pg/ml]和CRP浓度(18.5±4.3) mg/L比(9.5±4.1)mg/L、(12.4±3.7)mg/L比(7.1±3.5)mag/L]均降低;PCIA总按压次数减少(18.2±3.1)次/48h比(8.1±2.6)次/48 h],舒芬太尼用量降低(115±4)μg/48 h比(102±4)μg/48 h];恶心呕吐发生率(35.7%比7.1%)下降,排气排便时间(60±11)h比(48±13)h、(76±13)h比(66±12) h]缩短(P<0.05).结论 右美托咪定可缩短腹腔镜下胃大部切除患者术后肠麻痹时间,有利于肠蠕动的恢复.

关 键 词:右美托咪啶  假性肠梗阻  胃切除术

Effect of dexmedetomidine on postoperative enteroplegia in patients undergoing laparoscopic subtotal gastrectomy
Miao Yafei.Effect of dexmedetomidine on postoperative enteroplegia in patients undergoing laparoscopic subtotal gastrectomy[J].International Medicine & Health Guidance News,2017,23(8).
Authors:Miao Yafei
Abstract:Objective To evaluate the effect of dexmedetomidine on postoperative enteroplegia in patients undergoing laparoscopic subtotal gastrectomy.Methods Sixty patients,aged from 30 to 65 years old,with body mass index of 20-25 kg/m2,of ASA physical status Ⅰ or Ⅱ,were randomly divided into control group (group C) and dexmedetomidine group (group D) with the random number table,30 cases in each group.In group D,dexmedetomidine 1 μ g/kg was infused intravenously for l0 min,followed by continuous infusion of dexmedetomidine at 0.2 μ g · kg-1 · h-1 until 48 h post-surgery;while in group C the equal volume of normal saline was given instead.PCIA was performed with sufentanil 150 μ g + ondansetron 16 mg in 139 ml of normal saline within 48 h after operation (background infusion at 2 ml/h with a bolus dose of 0.5 ml and a 15 min lockout interval).Immediately before induction of anesthesia (T0,baseline),24 h after surgery (T3),and 48 h after surgery (T4),blood samples were collected for measurement of the levels of interleukin-6 (IL-6) and C-reactive protein (CRP).The number of attempts,consumption of sufentanil were recorded within 48h after operation.Results Compared with group C,the levels of IL-6 (51±13)pg/ml vs (38±12)pg/ml,(39±10)pg/ml vs (30±9)pg/ml] and CRP (18.5±4.3)mg/L vs (9.5±4.1)mg/L,(12.4±3.7)mg/L vs (7.1±3.5)mg/L] in group D were lower at T3,4,and the number of attempts was less (18.2±3.l)times/48h vs (8.l±2.6)times/48h],the consumption of sufentanil was less (115±4)μ g/48h vs (102±4)μ g/48h],the incidence of nausea and vomiting was lower (35.7% vs 7.1%),the time of flatus and defecation were shorter (60±11)h vs (48±13)h,(76±13)h vs (66±12)h] (P<0.05).Conclusion Dexmedetomidine can shorten time of postoperative enteroplegia in patients undergoing laparoscopic subtotal gastrectomy,and is beneficial to the recovery of intestinal peristalsis.
Keywords:Dexmedetomidine  Intestinal pseudoobstruction  Gastrectomy
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号